Neurocrine Biosciences, Inc.
NBIX
Market Cap$12.78B
Close$
$357.55
179.6% upside
Current Fair Value
179.6% upsideUndervalued by 179.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.78 Billion |
|---|---|
| Enterprise Value | $13.03 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.4 |
| Beta | 0.24 |
| Outstanding Shares | 99,700,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 42.09 |
|---|---|
| PEG | -51.46 |
| Price to Sales | 5.33 |
| Price to Book Ratio | 5.12 |
| Enterprise Value to Revenue | 5.4 |
| Enterprise Value to EBIT | 26.18 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Neurocrine Biosciences, Inc.
CEO: Kevin Gorman